BENJAMIN SWANSON: Open Payments
NPI 1528564135 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 20 payments from 11 companies in 2025. Trend: 2023 $392 · 2024 $367 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Novo Nordisk Inc | 2 | $35 |
| Corcept Therapeutics | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| ABBVIE INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: DOVATO, XIFAXAN, CABENUVA, Ozempic, Korlym, BREZTRI, PIFELTRO, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
